|
|
 |
|
Viewing report
|
|
|
|
Current Clinical Trials: Rheumatology
Informa Healthcare, Jan 2007
Current Clinical Trials: Rheumatology analyses the competitive landscape for drugs to treat rheumatic conditions, including rheumatoid arthritis, osteoarthritis, psoriatic arthritis, ankylosing spondylitis, scleroderma and fibromyalgia. The report reviews drugs currently on the market, their competitive position, and market size and growth potential. It also analyses new drugs in Phase II and III clinical trials based on data from the leading clinical trials database, TrialTrove to give a comprehensive picture of how the market for rheumatology treatments will develop over the coming years.
The report gives a detailed analysis of:
- Primary segments of the rheumatology drugs market
- Sales data for branded products
- Clinical trials (Phases I,II and III) of new treatments and the leading sponsors
- The outlook for each segment of the market and the impact that emerging treatments are likely to have
It will help you to:
- Plan your market entry strategy
- Identify partnership/investment opportunities
- Analyse the market position of your competitors
- Identify new technologies for licensing
- Assess the competitive landscape for your products
Customers who bought this item also bought
Will Emerging Agents Disrupt the Psoriatic Arthritis Market?
Ankylosing Spondylitis: How Have Biological Therapies Affected the Market?
Latin American Rheumatoid Arthritis Drugs Market
The Rheumatoid Arthritis Market - Competitive Landscape and Clinical Stage Analysis
Rheumatoid Arthritis Drug Discoveries: What The Future Holds
Pipeline Insight: Disease Modification In Rheumatoid Arthritis - Competition For The Anti-TNF Failure Patient Population Increases
Drug Therapy in Rheumatology Nursing, 2nd Edition
Pipeline Insight: Disease Modification in Rheumatoid Arthritis - New drug targets compete in crowded market
Osteoarthritis and Rheumatoid Arthritis: Opinion Leader Forum - Expert's Views and Perspectives on Diagnosis, Treatment, Product Performance and Closing the Need Gap
Therapeutic Clinical Intelligence - Rheumatoid Arthritis - 2009 Edition
Pain Therapeutics - Drugs, Markets and Companies
Treating COPD Comorbidities: A Market Opportunity for Systemic Anti-Inflammatory Agents?
|
|
|
|
